LFCR
LFCR
NASDAQ · Life Sciences Tools & Services

Lifecore Biomedical Inc

$4.58
+0.04 (+0.88%)
As of Aug 18, 1:45 PM ET ·
Financial Highlights (FY 2026)
Revenue
77.97M
Net Income
-18,542,028
Gross Margin
31.4%
Profit Margin
-23.8%
Rev Growth
-9.9%
D/E Ratio
4.18
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 31.4% 31.4% 44.5% 44.5%
Operating Margin -1.0% -0.9% 6.5% 6.6%
Profit Margin -23.8% -22.6% 5.3% 5.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 77.97M 86.54M 344.67M 265.26M
Gross Profit 24.46M 27.15M 153.43M 118.09M
Operating Income -756,292 -755,536 22.32M 17.47M
Net Income -18,542,028 -18,523,504 18.11M 14.22M
Gross Margin 31.4% 31.4% 44.5% 44.5%
Operating Margin -1.0% -0.9% 6.5% 6.6%
Profit Margin -23.8% -22.6% 5.3% 5.4%
Rev Growth -9.9% -9.9% +6.7% +0.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 72.84M 72.84M 31.30M 33.69M
Total Equity 17.44M 17.44M 172.81M 150.13M
D/E Ratio 4.18 4.18 0.18 0.22
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 4.97M 5.24M 26.32M 22.29M
Free Cash Flow 8.29M 10.33M